🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy and safety of secukinumab compared to p...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-09-29
Trial ID
NCT02267135
Treatments Being Tested
This study evaluated the effect of secukinumab compared to placebo on aorti...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-02-10
Trial ID
NCT02690701
Treatments Being Tested
The purpose of this study was to assess the efficacy and safety of secukinu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-06-16
Trial ID
NCT02547714
Treatments Being Tested
It is a randomized, double-blinded, single-dose, 3-arm parallel, comparativ...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2022-06-08
Trial ID
NCT04711343
Treatments Being Tested
Given the role of IL-17 in the development of entheseal-driven pathology, a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-11-02
Trial ID
NCT04488185
Treatments Being Tested
The primary purpose of this study is to assess efficacy, safety and tolerab...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-12-19
Trial ID
NCT03589885
The purpose of this study was to assess efficacy and safety data of secukin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-08-21
Trial ID
NCT01952015
Treatments Being Tested
The purpose of this study was to provide 16-week efficacy, safety and toler...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-05-29
Trial ID
NCT02294227
Treatments Being Tested
The purpose of this study was to assess the efficacy and safety of secukinu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-06-24
Trial ID
NCT04711902
Treatments Being Tested